Prognostic factors in purged marrow from patients with neuroblastoma receiving myeloablative treatment: Tumor cell number, N-myc protein, N-myc gene amplification and rate of hematologic recovery

International Journal of Oncology

Volumn 3, Issue 4, 1993, Pages 755-761

  Gazitt, Y ^a   Cantor, A ^a   He, Y J ^a   Koza, S ^a   Cohen, R J ^a   Graham Pole, J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; MELPHALAN;

ARTICLE; BONE MARROW PURGING; CHILD; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; ONCOGENE MYC; PROGNOSIS;

EID: 0027359065     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.3.4.755     Document Type: Article

References (0)